Fortunately, over past decades, the finding of some driver genes in NSCLC, such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) and kirsten rat sarcoma viral oncogene homolog (KRAS), was a major breakthrough in lung cancer field [4]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.